The discovery and synthesis of highly potent, A(2a) receptor agonists

Bioorganic and Medicinal Chemistry Letters

Volumn 10, Issue 4, 2000, Pages 403-406

  Keeling, Suzanne E ^a   Albinson, F David ^a   Ayres, Barry E ^a   Butchers, Peter R ^a   Chambers, C Lynn ^a   Cherry, Peter C ^a   Ellis, Frank ^a   Ewan, George B ^a   Gregson, Michael ^a   Knight, John ^a   Mills, Keith ^a   Ravenscroft, Paul ^a   Reynolds, Linda H ^a   Sanjar, Shahin ^a   Sheehan, Michael J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR; ADENOSINE DERIVATIVE;

ARTICLE; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; DRUG SOLUBILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LIPOPHILICITY; NEUTROPHIL; STRUCTURE ACTIVITY RELATION;

ADENOSINE; ANTI-INFLAMMATORY AGENTS; GTP-BINDING PROTEINS; RECEPTORS, PURINERGIC P1; SOLUBILITY; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 18244412405     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(00)00017-2     Document Type: Article

References (13)

1. Daly J.W. J. Med. Chem. 25:1982;197.
2. Jacobsen K.A., van Galen P.J.M., Williams M. J. Med. Chem. 35:1992;407.
3. Poulsen S.-A., Quinn R. J. Bioorg. Med. Chem. 6:1998;619.
4. Pantely G.A., Bristow J.D. Circulation. 82:1990;1854.
5. Trivedi, B. K.; Bridges, A. J.; Bruns, R. F. In Adenosine and Adenosine Receptors; Williams, M., Ed.; Humana: Clifton, NJ, 1990; pp 57-103.
6. Siddiqi, S. M.; Jacobsen, K. A.; Esker, J. L.; Olah, M. E.; Ji, X.; Melman, N.; Tiwari, K. N.; Secrist, III, J. A.; Schneller, S. W.; Cristalli, G.; Stiles, G. L.; Johnson, C. R.; Ijzerman, A. P. J. Med. Chem. 1995, 38, 1174 and pp 627-628 and references therein.
7. Marone G., Rosaria P., Sergio V. Int. Arch. Allergy Appl. Immunol. 77:1985;259.
8. Cronstein B.N., Rosenstein E.D., Kramer S.B., Weissmann G., Hirschhorn R. J. Immunol. 135:1985;1366.
9. Gurden M.F., Coates J., Ellis F., Evans B., Foster M., Hornby E., Kennedy I., Martin D.P., Strong P., Vardey C.J., Wheeldon A. Br. J. Pharmacol. 109:1993;693.
10. Kennedy I., Gurden M., Strong P. Gen. Pharmacol. 23:1992;303.
11. 50 figures for NECA are geometric mean values, with 95% confidence limits shown in parentheses where n=number of observations. Where ECR figures are based on n is >=2, arithmetic mean values are given.
12. Trivedi B.K., Bruns R.F. J. Med. Chem. 32:1989;1667.
13. Francis J.E., Webb R.L., Ghai G.R., Hutchison A.J., Moskal M.A., de Jesus R., Yokoyama R., Rovinski S.L., Contrado N., Dotson R., Barclay B., Stone G.A., Jarvis M.F. J. Med. Chem. 34:1991;2570.